COMPOSITIONS PHARMACEUTIQUES COMPRENANT UN COMPOSÉ DEXTROMÉTHORPHANE ET DE LA QUINIDINE PERMETTANT LE TRAITEMENT DE L'AGITATION DANS LE CADRE D'UNE DÉMENCE
The present disclosure is related to methods of treating agitation and/or aggression and/or associated symptoms in subjects with dementia, including, dementia associated with Alzheimer's disease. The method includes administering to a subject in need thereof a dextromethorphan compound, or a pharmaceutically acceptable salt thereof, in combination with quinidine, or a pharmaceutically acceptable salt thereof. The disclosure in certain aspects is also related to compositions that are used for treating agitation and/or aggression and/or associated symptoms in subjects suffering from Alzheimer's disease.